Boomerang-Shaped Cartilage Graft in Endoscopic Tympanoplasty
Boomerang-Shaped Cartilage/Perichondrial Graft in Endoscopic Tympanoplasty for Anterior or Subtotal Tympanic Membrane Perforations
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
This study evaluates the anatomical and functional outcomes of using a boomerang-shaped chondroperichondrial graft in endoscopic Type I tympanoplasty for repairing anterior or subtotal tympanic membrane perforations. Anterior and subtotal eardrum perforations represent challenging surgical scenarios due to limited visualization, lack of anterior graft support, and higher risks of graft retraction, medialization, or residual perforation. The boomerang-shaped cartilage and perichondrium graft provides a sturdy cartilage framework along the anterior border to secure structural support, while maintaining a thin perichondrial layer over the functional vibratory area to facilitate acoustic transmission. All enrolled participants undergo endoscopic Type I tympanoplasty using this autologous grafting technique. Follow-up assessments are conducted at 1, 3, and 6 months after surgery to determine successful graft uptake, evaluate hearing improvement (via pure-tone audiometry and air-bone gap closure), and monitor for complications such as blunting, retraction, lateralization, or infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2026
CompletedFirst Posted
Study publicly available on registry
September 17, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2027
September 17, 2026
September 1, 2026
1 year
September 11, 2026
September 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Graft Uptake Rate
Percentage of patients achieving complete anatomical closure and intact healing of the tympanic membrane perforation without residual defect, verified by postoperative otoscopic and endoscopic examination.
6 months postoperatively
Study Arms (1)
Boomerang-Shaped Chondroperichondrial Graft
EXPERIMENTALPatients undergo endoscopic Type I tympanoplasty using an autologous boomerang-shaped chondroperichondrial graft for the repair of anterior or subtotal tympanic membrane perforations. Graft uptake, audiometric outcomes (pure-tone audiometry thresholds and air-bone gap closure), and postoperative complications are assessed over a 6-month follow-up period.
Interventions
Endoscopic Type I tympanoplasty performed using a rigid endoscope to repair anterior or subtotal tympanic membrane perforations. The autologous boomerang-shaped chondroperichondrial graft provides a stable anterior cartilage framework to prevent graft medialization, retraction, and residual perforation, while preserving a thin perichondrial layer over the functional vibratory surface to optimize acoustic transfer. Anatomical graft uptake and complication rates are monitored at 1, 3, and 6 months postoperatively, and functional hearing outcomes (pure-tone audiometry thresholds and air-bone gap closure) are measured at 6 months.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Anterior or subtotal tympanic membrane perforation
- Dry ear for at least 3 months prior to surgery
- Intact and mobile ossicular chain on clinical and intraoperative assessment
- Aerated middle ear with healthy or near-normal middle ear mucosa
- No evidence of cholesteatoma
- Ability to attend all scheduled postoperative follow-up visits
- Provision of written informed consent
You may not qualify if:
- Active ear discharge at the time of surgery
- Presence of cholesteatoma
- Marginal or attic perforation associated with pathology requiring mastoid surgery
- Ossicular discontinuity or erosion requiring ossiculoplasty
- Significant adhesive otitis media
- Previous failed tympanoplasty in the same ear
- Severe Eustachian tube dysfunction associated with adhesive disease
- Craniofacial anomalies affecting the ear
- Uncontrolled systemic disease contraindicating surgery
- Narrow external auditory canal precluding endoscopic access
- Inability to complete the planned follow-up period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
September 11, 2026
First Posted
September 17, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
November 1, 2027
Last Updated
September 17, 2026
Record last verified: 2026-09